Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 16, Issue 5, Pages 10578-10600Publisher
MDPI
DOI: 10.3390/ijms160510578
Keywords
cellular implants; genetic engineering; encapsulation; passive immunization; recombinant antibodies; Alzheimer's disease; cytokine; adjuvant; cancer vaccine
Funding
- Swiss Commission for Technology and Innovation (CTI) [14666.1 PFLS-LS]
Ask authors/readers for more resources
Ex vivo gene therapy using retrievable encapsulated cellular implants is an effective strategy for the local and/or chronic delivery of therapeutic proteins. In particular, it is considered an innovative approach to modulate the activity of the immune system. Two recently proposed therapeutic schemes using genetically engineered encapsulated cells are discussed here: the chronic administration of monoclonal antibodies for passive immunization against neurodegenerative diseases and the local delivery of a cytokine as an adjuvant for anti-cancer vaccines.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
